Spatiotemporal Gene Expression Analysis Services
Inquiry
As a preclinical CRO specializing in oncology, Alfa Cytology offers comprehensive spatiotemporal gene expression analysis services designed to elucidate the spatial architecture and dynamic evolution of tumors. By integrating spatial transcriptomics with multiplex immunofluorescence technologies, we enable quantitative profiling of gene expression dynamics across distinct tumor regions while preserving native tissue architecture, empowering you to decipher tumor heterogeneity, microenvironmental interactions, and disease progression in three-dimensional space.
Introduction to Spatiotemporal Gene Expression
Conventional gene expression profiling methods, such as bulk RNA-seq, average signals across entire tissue samples, thereby obscuring the spatial heterogeneity that is critical to tumor biology and therapeutic response. Tumors are not homogeneous masses but rather comprise diverse cell populations distributed across distinct anatomical regions, each exhibiting unique transcriptional states and functional behaviors. Spatiotemporal gene expression analysis represents a paradigm shift in cancer research. This emerging approach synergizes the morphological insights of histology with the high-throughput capabilities of transcriptomics. By leveraging multiplex fluorescent labeling, DNA/RNA tagging, and spatial barcoding technologies, spatiotemporal analysis enables simultaneous detection of gene expression at precise spatial coordinates on tissue sections.
- Revealing cellular heterogeneity: Identify and map the distribution of distinct cell populations within tumor tissues, uncovering clonal architectures and spatial organization of cancer cells.
- Dissecting the tumor microenvironment: Chart immune infiltration patterns, stromal cell distributions, and cellular interaction networks that drive tumor progression, immune evasion, and metastasis.
- Tracking temporal dynamics: Monitor changes in gene expression patterns over time during disease progression or in response to therapeutic intervention.
- Identifying therapeutic targets: Pinpoint spatially vulnerable regions that may serve as actionable targets for precision oncology.
Fig. 1 Spatially resolved single cell multiomic atlas of GB tumour heterogeneity. (de Jong G, et al.; 2026)
Our Services
At Alfa Cytology, we offer a comprehensive suite of spatiotemporal gene expression analysis services tailored to meet the diverse needs of oncology researchers. Leveraging advanced technology platforms and a skilled scientific team, we are committed to delivering high-quality data and actionable biological insights that drive breakthrough discoveries in cancer research. Our services include, but are not limited to:
Spatial Transcriptomics Analysis
Spatial transcriptomics enables simultaneous profiling of gene expression across thousands of cells while retaining spatial information. Using high‑density spatial capture probes with coordinate identifiers (CIDs), we directly capture mRNA molecules from tissue sections and map them back to their original spatial locations. This module provides a panoramic view of transcriptional activity across entire tissue sections, facilitating the discovery of spatially restricted gene signatures.
Multiplex Imaging Spatial Analysis
We employ advanced multiplex imaging technologies to visualize and quantify multiple biomarkers simultaneously within tissue samples. By combining fluorescent, DNA, RNA, and isotopic labels, we can detect dozens to thousands of tumor subclones or molecular markers in their native spatial context. This approach enables concurrent assessment of cell lineage markers, activation states, and functional proteins.
Spatial Proteomics Analysis
Our spatial proteomics service enables deep protein profiling within the tissue architecture. Utilizing advanced imaging technologies coupled with antibody‑based detection, we analyze the spatial distribution and abundance of specific proteins across different cellular compartments. This module complements transcriptomic data by confirming protein expression and localization, thereby adding a functional dimension.
Data Integration and Analysis
Our bioinformatics experts employ state‑of‑the‑art algorithms and computational tools to integrate spatial omics data with other omics datasets, enabling a systems‑level understanding of tumor biology. We provide customized analysis pipelines and interactive visualization platforms to facilitate data exploration and hypothesis generation.
Technology Highlights
- High-resolution spatial localization: Achieve subcellular resolution down to 500 nm for precise mapping of gene expression patterns.
- Large field of view: Standard chip size of 1 cm × 1 cm, expandable to 2 cm × 3 cm to accommodate comprehensive tissue analysis.
- Broad sample compatibility: Support for both fresh-frozen (FF) and formalin-fixed paraffin-embedded (FFPE) tissues.
- Single-cell segmentation: Advanced algorithms enable cell-level spatial analysis.
- Customizable panel design: Tailored biomarker panels designed to address your specific research questions.
Applications of Spatiotemporal Gene Expression Analysis Services
Spatiotemporal gene expression analysis serves as a powerful tool across multiple dimensions of oncology research, transforming spatial transcriptomic information into decisionready biological data:

Tumor Heterogeneity and Subtyping
Spatial analysis identifies tumor subregions with distinct molecular features, revealing intratumoral heterogeneity that drives disease progression and treatment resistance. This approach facilitates molecular subtyping of tumors based on spatially resolved expression patterns.

Tumor Microenvironment Characterization
By mapping the spatial distribution of immune cells, stromal cells, and cancer cells, our analysis uncovers the organizational architecture of the tumor microenvironment, including immune infiltration patterns, tertiary lymphoid structure formation, and immuneexcluded regions. These insights are critical for understanding immune evasion mechanisms and optimizing immunotherapeutic strategies.

Drug Penetration and Response Region Mapping
Spatial analysis enables tracking of drug penetration gradients and response regions within tumor tissues, identifying resistant and sensitive zones. This capability is essential for evaluating drug efficacy and optimizing therapeutic regimens.

Biomarker Discovery and Validation
Identification of spatially restricted biomarkers offers new opportunities for diagnostic and therapeutic development. Our analysis can reveal regionspecific expression signatures that serve as prognostic indicators or therapeutic targets.
Workflow of Spatiotemporal Gene Expression Analysis Services
Project Consultation and Study Design
Our scientific team engages in indepth discussions with you to fully understand your research objectives, sample types, and spatial analysis requirements.
Service Selection and Customization
Based on your specific needs, we select and tailor the appropriate spatial omics solution—whether spatial transcriptomics, multiplex imaging analysis, or an integrated multiomics approach.
Sample Preparation and Quality Control
Our experienced scientists perform tissue processing, sectioning, staining (H&E or ssDNA), and quality assessment under stringent quality control protocols to ensure sample suitability for spatial analysis.
Permeabilization Optimization
Permeabilization times are optimized for each sample type to ensure efficient mRNA capture while preserving tissue morphology.
Data Generation
We execute spatial library construction, in situ RNA capture, reverse transcription, and sequencing (on DNBSEQ or equivalent platforms) with rigorous internal quality controls, delivering comprehensive data at high resolution and reproducibility.
Data Analysis and Interpretation
Our bioinformatics team performs customized spatial analyses, including tissue segmentation, spatial clustering, differential region identification, trajectory inference, and ligand–receptor interaction inference, to transform raw spatial data into biological insights.
Downstream Application Integration
Your spatial gene expression data can be seamlessly integrated with our downstream application platforms, including target validation, pharmacodynamic evaluation, and INDenabling studies.
Alfa Cytology stands as your most trusted partner in oncology spatiotemporal gene expression research. We offer a full spectrum of spatiotemporal analysis services, from sample processing and data generation to advanced spatial mining and biological interpretation, supporting your target discovery, pharmacodynamic evaluation, and IND-enabling studies through every step of the journey. Please don't hesitate to contact us to receive your customized spatiotemporal gene expression analysis solution.
Reference
- de Jong G, et al. A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneity. Cancer Res. 2026;86(7 Suppl):Abstract nr 7509.
For research use only.
Related Services